{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T15:01:58Z","timestamp":1785250918473,"version":"3.55.0"},"reference-count":74,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T00:00:00Z","timestamp":1778716800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1R01AI152219\\u201301"],"award-info":[{"award-number":["1R01AI152219\\u201301"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019742","name":"West Virginia Science & Research","doi-asserted-by":"publisher","award":["HEPC.dsr18.6"],"award-info":[{"award-number":["HEPC.dsr18.6"]}],"id":[{"id":"10.13039\/100019742","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017313","name":"West Virginia Higher Education Policy Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017313","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009455","name":"West Virginia University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009455","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.vaccine.2026.128696","type":"journal-article","created":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T17:43:43Z","timestamp":1779558223000},"page":"128696","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Evaluation of EcoCRM, virus-like particles, and mRNA as vaccine platforms against Borrelia burgdorferi"],"prefix":"10.1016","volume":"86","author":[{"given":"Carleena M.","family":"Rocuskie-Marker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annalisa B.","family":"Huckaby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivia M.","family":"Conaway","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gage M.","family":"Pyles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Spencer R.","family":"Dublin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William T.","family":"Witt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine B.","family":"Blackwood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"de la Paz Gutierrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua M.","family":"Hall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel R.","family":"Ulicny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Padden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaughnessy","family":"Shephard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua","family":"Chapman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toby","family":"Zapotocky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeanneliese","family":"Cannon-Blachere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerrington","family":"Peasak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathaniel A.","family":"Rader","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauren","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beau Rex","family":"Hankinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isaac","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"DaNaylee A.","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mason","family":"Nunley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dylan","family":"Willis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine S.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Casey","family":"Cunningham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly L.","family":"Weaver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F. Heath","family":"Damron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariette","family":"Barbier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2026.128696_bb0005","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/art.1780200102","article-title":"An epidemic of oligoarticular arthritis in children and adults in three Connecticut communities","volume":"20","author":"Steere","year":"1977","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.vaccine.2026.128696_bb0010","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1093\/infdis\/jiae230","article-title":"Lyme disease surveillance and epidemiology in the United States: a historical perspective","volume":"230","author":"Mead","year":"2024","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2026.128696_bb0015","doi-asserted-by":"crossref","first-page":"118","DOI":"10.15585\/mmwr.mm7306a1","article-title":"Surveillance for Lyme disease after implementation of a revised case definition \u2014 United States, 2022","volume":"73","author":"Kugeler","year":"2024","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2026.128696_bb0020","series-title":"Lyme disease","author":"Center for Disease Control and Prevention","year":"2026"},{"key":"10.1016\/j.vaccine.2026.128696_bb0025","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1542\/pir.35.12.500","article-title":"Borrelia burgdorferi (Lyme disease)","volume":"35","author":"Shapiro","year":"2014","journal-title":"Pediatr Rev"},{"key":"10.1016\/j.vaccine.2026.128696_bb0030","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/nrmicro2714","article-title":"Of ticks, mice and men: understanding the dual-host lifestyle of Lyme disease spirochaetes","volume":"10","author":"Radolf","year":"2012","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.vaccine.2026.128696_bb0035","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2016.90","article-title":"Lyme borreliosis","volume":"2","author":"Steere","year":"2016","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.vaccine.2026.128696_bb0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.ttbdis.2023.102233","article-title":"Changes in the geographic distribution of the blacklegged tick, Ixodes scapularis, in the United States","volume":"14","author":"Eisen","year":"2023","journal-title":"Ticks and Tick-borne Diseases"},{"key":"10.1016\/j.vaccine.2026.128696_bb0045","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1093\/genetics\/160.3.833","article-title":"Geographic uniformity of the Lyme disease spirochete (Borrelia burgdorferi) and its shared history with tick vector (Ixodes scapularis) in the northeastern United States","volume":"160","author":"Qiu","year":"2002","journal-title":"Genetics"},{"key":"10.1016\/j.vaccine.2026.128696_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.ttbdis.2023.102161","article-title":"Mechanistic movement models to predict geographic range expansions of ticks and tick-borne pathogens: case studies with Ixodes scapularis and Amblyomma americanum in eastern North America","volume":"14","author":"Tardy","year":"2023","journal-title":"Ticks and Tick-borne Diseases"},{"key":"10.1016\/j.vaccine.2026.128696_bb0055","doi-asserted-by":"crossref","first-page":"15013","DOI":"10.1073\/pnas.0903810106","article-title":"Phylogeography of Borrelia burgdorferi in the eastern United States reflects multiple independent Lyme disease emergence events","volume":"106","author":"Hoen","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2026.128696_bb0060","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1186\/s13071-025-07047-9","article-title":"Variables for habitat and vertebrate hosts of Ixodes scapularis are the best ecological predictors of the spatial spread of Lyme disease in the United States (2010\u20132019)","volume":"18","author":"Kelly","year":"2025","journal-title":"Parasit Vectors"},{"key":"10.1016\/j.vaccine.2026.128696_bb0065","doi-asserted-by":"crossref","DOI":"10.1128\/jb.00116-24","article-title":"Hitchhiker\u2019s guide to Borrelia burgdorferi","volume":"206","author":"Bourgeois","year":"2024","journal-title":"J Bacteriol"},{"key":"10.1016\/j.vaccine.2026.128696_bb0070","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1038\/s41559-017-0282-8","article-title":"Genomic insights into the ancient spread of Lyme disease across North America","volume":"1","author":"Walter","year":"2017","journal-title":"Nat Ecol Evol"},{"key":"10.1016\/j.vaccine.2026.128696_bb0075","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1128\/CVI.00302-16","article-title":"Live attenuated Borrelia burgdorferi targeted mutants in an infectious strain background protect mice from challenge infection","volume":"23","author":"Hahn","year":"2016","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2026.128696_bb0080","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1186\/s13071-024-06518-9","article-title":"Spatial and temporal distribution of Ixodes scapularis and tick-borne pathogens across the northeastern United States","volume":"17","author":"Price","year":"2024","journal-title":"Parasit Vectors"},{"key":"10.1016\/j.vaccine.2026.128696_bb0085","series-title":"Lyme Disease. in StatPearls StatPearls Publishing, Treasure Island (FL)","author":"Skar","year":"2024"},{"key":"10.1016\/j.vaccine.2026.128696_bb0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S0950268806007096","article-title":"The Lyme vaccine: a cautionary tale","volume":"135","author":"Nigrovic","year":"2007","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.vaccine.2026.128696_bb0095","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0184357","article-title":"The novel Lyme borreliosis vaccine VLA15 shows broad protection against Borrelia species expressing six different OspA serotypes","volume":"12","author":"Comstedt","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2026.128696_bb0100","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1001\/jama.1994.03510460056033","article-title":"Safety and immunogenicity of a recombinant outer surface protein a Lyme vaccine","volume":"271","author":"Keller","year":"1994","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2026.128696_bb0105","doi-asserted-by":"crossref","first-page":"2702","DOI":"10.1016\/j.ymthe.2023.07.022","article-title":"Development of an mRNA-lipid nanoparticle vaccine against Lyme disease","volume":"31","author":"Pine","year":"2023","journal-title":"Mol Ther"},{"key":"10.1016\/j.vaccine.2026.128696_bb0110","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1056\/NEJM199807233390401","article-title":"Vaccination against Lyme disease with recombinant Borrelia burgdorferi outer-surface lipoprotein a with adjuvant","volume":"339","author":"Steere","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2026.128696_bb0115","doi-asserted-by":"crossref","first-page":"661","DOI":"10.7326\/0003-4819-132-8-200004180-00009","article-title":"The Lyme disease vaccine: conception, development, and implementation","volume":"132","author":"Thanassi","year":"2000","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.vaccine.2026.128696_bb0120","author":"Clinical Trials.gov"},{"key":"10.1016\/j.vaccine.2026.128696_bb0125","doi-asserted-by":"crossref","first-page":"210","DOI":"10.3201\/eid1402.070725","article-title":"Effectiveness of personal protective measures to prevent Lyme disease","volume":"14","author":"V\u00e1zquez","year":"2008","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2026.128696_bb0130","series-title":"Borrelia: Molecular biology, host interaction, and pathogenesis","year":"2010"},{"key":"10.1016\/j.vaccine.2026.128696_bb0135","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.3390\/microbiolres14040136","article-title":"Evaluation of outer surface protein vaccine candidates of Borrelia burgdorferi for Lyme disease","volume":"14","author":"Liekni\u0146a","year":"2023","journal-title":"Microbiol Res"},{"key":"10.1016\/j.vaccine.2026.128696_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2024.06.051","article-title":"Antibody-mediated immunological memory correlates with long-term Lyme veterinary vaccine protection in mice","author":"Gutierrez","year":"2024","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2026.128696_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/S1473-3099(24)00372-4","article-title":"Immunogenicity and safety of an 18-month booster dose of the VLA15 Lyme borreliosis vaccine candidate after primary immunisation in healthy adults in the USA: results of the booster phase of a randomised, controlled, phase 2 trial","author":"Ghadge","year":"2024","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2026.128696_bb0150","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1107\/S2053230X23002364","article-title":"Monomeric crystal structure of the vaccine carrier protein CRM 197 and implications for vaccine development","volume":"79","author":"Gallagher","year":"2023","journal-title":"Acta Crystallogr F Struct Biol Commun"},{"key":"10.1016\/j.vaccine.2026.128696_bb0155","doi-asserted-by":"crossref","DOI":"10.1038\/s41541-022-00451-7","article-title":"Intranasal administration of BReC-CoV-2 COVID-19 vaccine protects K18-hACE2 mice against lethal SARS-CoV-2 challenge","volume":"7","author":"Wong","year":"2022","journal-title":"npj Vaccines"},{"key":"10.1016\/j.vaccine.2026.128696_bb0160","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.3390\/v15051109","article-title":"Virus-like particle vaccines and platforms for vaccine development","volume":"15","author":"Kheirvari","year":"2023","journal-title":"Viruses"},{"key":"10.1016\/j.vaccine.2026.128696_bb0165","doi-asserted-by":"crossref","DOI":"10.1038\/srep19234","article-title":"Plug-and-display: decoration of virus-like particles via isopeptide bonds for modular immunization","volume":"6","author":"Brune","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.vaccine.2026.128696_bb0170","doi-asserted-by":"crossref","DOI":"10.1128\/iai.00270-24","article-title":"Virus-like particles displaying the mature C-terminal domain of filamentous hemagglutinin are immunogenic and protective against Bordetella pertussis respiratory infection in mice","volume":"92","author":"Pyles","year":"2024","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2026.128696_bb0175","doi-asserted-by":"crossref","first-page":"8855","DOI":"10.1021\/acsnano.8b02805","article-title":"Engineering a rugged Nanoscaffold to enhance plug-and-display vaccination","volume":"12","author":"Bruun","year":"2018","journal-title":"ACS Nano"},{"key":"10.1016\/j.vaccine.2026.128696_bb0180","doi-asserted-by":"crossref","DOI":"10.1186\/s12951-016-0181-1","article-title":"Bacterial superglue enables easy development of efficient virus-like particle based vaccines","volume":"14","author":"Thrane","year":"2016","journal-title":"J Nanobiotechnol"},{"key":"10.1016\/j.vaccine.2026.128696_bb0185","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.procbio.2022.10.020","article-title":"Virus-like nanoparticles (VLPs) based technology in the development of breast cancer vaccines","volume":"123","author":"Arab","year":"2022","journal-title":"Process Biochem"},{"key":"10.1016\/j.vaccine.2026.128696_bb0190","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1038\/s41423-022-00897-8","article-title":"Virus-like particle vaccinology, from bench to bedside","volume":"19","author":"Mohsen","year":"2022","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.vaccine.2026.128696_bb0195","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/nrd.2017.243","article-title":"mRNA vaccines \u2014 a new era in vaccinology","volume":"17","author":"Pardi","year":"2018","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.vaccine.2026.128696_bb0200","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofaf695.1670","article-title":"P-1485. Safety and immunogenicity of mRNA-1982 and mRNA-1975, mRNA vaccine candidates for prevention of Lyme disease in healthy adults: interim results of a phase 1\/2, randomized, observer-blind, placebo-controlled, dose-ranging trial","volume":"13","author":"Lin","year":"2026","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.vaccine.2026.128696_bb0205","doi-asserted-by":"crossref","DOI":"10.1038\/s41541-025-01326-3","article-title":"Polyvalent mRNA vaccine targeting outer surface protein C affords multi-strain protection against Lyme disease","volume":"11","author":"Pfeifle","year":"2025","journal-title":"npj Vaccines"},{"key":"10.1016\/j.vaccine.2026.128696_bb0210","article-title":"The B7-1 cytoplasmic tail enhances intracellular transport and mammalian cell surface display of chimeric proteins in the absence of a linear ER export motif","volume":"8","author":"Lin","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2026.128696_bb0215","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0116878","article-title":"Optimization of heavy chain and light chain signal peptides for high level expression of therapeutic antibodies in CHO cells","volume":"10","author":"Haryadi","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2026.128696_bb0220","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1126\/science.2237407","article-title":"Protection of mice against the Lyme disease agent by immunizing with recombinant OspA","volume":"250","author":"Fikrig","year":"1990","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2026.128696_bb0225","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2023.1216364","article-title":"SpyTag\/SpyCatcher display of Influenza M2e peptide on Norovirus-like particle provides stronger immunization than direct genetic fusion","volume":"13","author":"Lampinen","year":"2023","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.vaccine.2026.128696_bb0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtn.2025.102514","article-title":"A Lyme disease mRNA vaccine targeting Borrelia burgdorferi OspA induces strong immune responses and prevents transmission in mice","volume":"36","author":"Tahir","year":"2025","journal-title":"Molecular Therapy Nucleic Acids"},{"key":"10.1016\/j.vaccine.2026.128696_bb0235","doi-asserted-by":"crossref","first-page":"702","DOI":"10.3390\/vaccines13070702","article-title":"An mRNA vaccine expressing blood-stage malaria antigens induces complete protection against lethal plasmodium yoelii","volume":"13","author":"Ott","year":"2025","journal-title":"Vaccines"},{"key":"10.1016\/j.vaccine.2026.128696_bb0240","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41541-023-00783-y","article-title":"mRNA vaccines expressing malaria transmission-blocking antigens Pfs25 and Pfs230D1 induce a functional immune response","volume":"9","author":"Scaria","year":"2024","journal-title":"npj Vaccines"},{"key":"10.1016\/j.vaccine.2026.128696_bb0245","series-title":"Attenuated influenza virions expressing the SARS-CoV-2 receptor-binding domain induce neutralizing antibodies in mice","author":"Loes","year":"2020"},{"key":"10.1016\/j.vaccine.2026.128696_bb0250","doi-asserted-by":"crossref","first-page":"2877","DOI":"10.1016\/j.immuni.2021.11.001","article-title":"Lipid nanoparticles enhance the efficacy of mRNA and protein subunit vaccines by inducing robust T follicular helper cell and humoral responses","volume":"54","author":"Alameh","year":"2021","journal-title":"Immunity"},{"key":"10.1016\/j.vaccine.2026.128696_bb0255","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0079022","article-title":"Evaluation of OspA vaccination-induced serological correlates of protection against Lyme Borreliosis in a mouse model","volume":"8","author":"Schwendinger","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2026.128696_bb0275","doi-asserted-by":"crossref","DOI":"10.1128\/IAI.00956-19","article-title":"The factor H-binding site of CspZ as a protective target against multistrain, tick-transmitted Lyme Disease","volume":"88","author":"Marcinkiewicz","year":"2020","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2026.128696_bb0280","doi-asserted-by":"crossref","first-page":"819","DOI":"10.3390\/vaccines10050819","article-title":"An overview of vaccine adjuvants: current evidence and future perspectives","volume":"10","author":"Facciol\u00e0","year":"2022","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.vaccine.2026.128696_bb0285","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/j.vaccine.2019.10.073","article-title":"Immunogenicity of the Lyme disease antigen OspA, particleized by cobalt porphyrin-phospholipid liposomes","volume":"38","author":"Federizon","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2026.128696_bb0290","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/s41541-020-0183-8","article-title":"Design of a broadly reactive Lyme disease vaccine","volume":"5","author":"Kamp","year":"2020","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.vaccine.2026.128696_bb0295","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s13273-021-00171-4","article-title":"Modifications of mRNA vaccine structural elements for improving mRNA stability and translation efficiency","volume":"18","author":"Kim","year":"2022","journal-title":"Mol Cell Toxicol"},{"key":"10.1016\/j.vaccine.2026.128696_bb0300","doi-asserted-by":"crossref","first-page":"4632","DOI":"10.1128\/iai.62.10.4632-4636.1994","article-title":"Biological activities of native and recombinant Borrelia burgdorferi outer surface protein a: dependence on lipid modification","volume":"62","author":"Weis","year":"1994","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2026.128696_bb0305","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1016\/S0264-410X(96)00146-6","article-title":"Evaluation of the safety, reactogenicity and immunogenicity of three recombinant outer surface protein (OspA) Lyme vaccines in healthy adults","volume":"14","author":"Vanhoecke","year":"1996","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2026.128696_bb0310","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtn.2025.102564","article-title":"Ticking off Lyme disease: OspA mRNA vaccine halts infection in mouse model","volume":"36","author":"He","year":"2025","journal-title":"Molecular Therapy Nucleic Acids"},{"key":"10.1016\/j.vaccine.2026.128696_bb0315","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/s13567-015-0229-5","article-title":"An in vitro model to assess the immunosuppressive effect of tick saliva on the mobilization of inflammatory monocyte-derived cells","volume":"46","author":"Vachiery","year":"2015","journal-title":"Vet Res"},{"key":"10.1016\/j.vaccine.2026.128696_bb0320","doi-asserted-by":"crossref","DOI":"10.1128\/AEM.02552-16","article-title":"Multistrain infections with Lyme Borreliosis pathogens in the tick vector","volume":"83","author":"Durand","year":"2017","journal-title":"Appl Environ Microbiol"},{"key":"10.1016\/j.vaccine.2026.128696_bb0325","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1603\/033.046.0330","article-title":"Transovarial transmission of Francisella -like endosymbionts and Anaplasma phagocytophilum variants in Dermacentor albipictus (Acari: Ixodidae)","volume":"46","author":"Baldridge","year":"2009","journal-title":"J Med Entomol"},{"key":"10.1016\/j.vaccine.2026.128696_bb0330","doi-asserted-by":"crossref","first-page":"4145","DOI":"10.1128\/JCM.39.11.4145-4148.2001","article-title":"Use of quantitative PCR to measure density of Borrelia burgdorferi in the midgut and salivary glands of feeding tick vectors","volume":"39","author":"Piesman","year":"2001","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2026.128696_bb0335","doi-asserted-by":"crossref","first-page":"115","DOI":"10.3201\/eid0802.010198","article-title":"Vector interactions and molecular adaptations of Lyme disease and relapsing fever spirochetes associated with transmission by ticks","volume":"8","author":"Schwan","year":"2002","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2026.128696_bb0340","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/s13071-016-1380-1","article-title":"Virulence of the Lyme disease spirochete before and after the tick bloodmeal: a quantitative assessment","volume":"9","author":"Kasumba","year":"2016","journal-title":"Parasit Vectors"},{"key":"10.1016\/j.vaccine.2026.128696_bb0345","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/s13567-015-0229-5","article-title":"An in vitro model to assess the immunosuppressive effect of tick saliva on the mobilization of inflammatory monocyte-derived cells","volume":"46","author":"Vachiery","year":"2015","journal-title":"Vet Res"},{"key":"10.1016\/j.vaccine.2026.128696_bb0350","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1186\/1471-2180-12-157","article-title":"Comparative molecular analyses of Borrelia burgdorferi sensu stricto strains B31 and N40D10\/E9 and determination of their pathogenicity","volume":"12","author":"Chan","year":"2012","journal-title":"BMC Microbiol"},{"key":"10.1016\/j.vaccine.2026.128696_bb0355","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2018.01722","article-title":"Infection kinetics and tropism of Borrelia burgdorferi sensu lato in mouse after natural (via ticks) or artificial (needle) infection depends on the bacterial strain","volume":"9","author":"Sertour","year":"2018","journal-title":"Front Microbiol"},{"key":"10.1016\/j.vaccine.2026.128696_bb0360","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1093\/infdis\/167.4.971","article-title":"Mode of inoculation of the Lyme disease agent Borrelia burgdorferi influences infection and immune responses in inbred strains of mice","volume":"167","author":"Gern","year":"1993","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2026.128696_bb0365","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1128\/jcm.34.9.2297-2299.1996","article-title":"Accelerated infectivity of tick-transmitted Lyme disease spirochetes to vector ticks","volume":"34","author":"Shih","year":"1996","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2026.128696_bb0370","doi-asserted-by":"crossref","first-page":"S1442","DOI":"10.1093\/clinids\/11.Supplement_6.S1442","article-title":"Pathophysiology of the Lyme disease spirochete, Borrelia burgdorferi, in Ixodid ticks","volume":"11","author":"Burgdorfer","year":"1989","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2026.128696_bb0375","first-page":"1309","article-title":"Transmission cycle of tick-borne infections and co-infections","volume":"11","author":"Rocha","year":"2022","journal-title":"Animal Models and Diseases Pathogens"},{"key":"10.1016\/j.vaccine.2026.128696_bb0380","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/JCM.36.1.1-5.1998","article-title":"First isolation and cultivation of Borrelia burgdorferi sensu lato from Missouri","volume":"36","author":"Oliver","year":"1998","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2026.128696_bb0385","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.838504","article-title":"Long-term analysis of pertussis vaccine immunity to identify potential markers of vaccine-induced memory associated with whole cell but not acellular pertussis immunization in mice","volume":"13","author":"Weaver","year":"2022","journal-title":"Front Immunol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26005050?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26005050?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T14:39:16Z","timestamp":1785249556000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X26005050"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":74,"alternative-id":["S0264410X26005050"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.128696","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of EcoCRM, virus-like particles, and mRNA as vaccine platforms against Borrelia burgdorferi","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.128696","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"128696"}}